Technical feasibility

SECTION I: Testing

 

1

Has the R & D result been tested?

YES

x

NO

 

 

The following question is replied according to the reply in question 1

 

If yes

 

1a

In what mode has the result been tested?

•             Prototype

•             Pilot Application

•             Alpha/BETA testing

 

Tests were carried out on rats and mice.

 

 

 

1b. Please describe and discuss the testing results
Muscle regeneration is faster with 20-30%. Near low transfection rate reaches high and fast muscle-wide regeneration.

 

 

If no:

 

1c

Describe what type of testing does the R&D result need?
Detailed comment

 

 

 

1d. What is the time needed for testing?
 
1e. What is the cost needed for testing?
 

 

 

SECTION 2: Current Stage of Development

 

2a

To what extent does the development team have technical resources for supporting the production of a new product? (Researchers, human resources, hardware, etc. )
A preclinical labor is needed, but they have not any.

 

 

2b

What are the technical issues that need to be tackled for full deployment, if needed?
Neither human nor toxicology testing was not yet done. Sick mice (wasting) was not tested.

 

2c

What additional technical resources are needed for the production of this new product?
They are looking for product development partners to develop the transfection kit through a licence agreement.

 

2d

Overall assessment of the current stage of technical development.
The basic research stage has been successfully closed; development is now entering the preclinical trial phase.

 

 

 

 

SECTION 3: Deployment

3a

Define the demands for large scale production in terms of
  • Materials
 

 

 

 

  • technologies, tools, machineries
 

 

 

 

  • Staff effort
 

 

 

 

 

 

SECTION 4: Overall Assessment

 

1

What is you overall assessment of the technical feasibility of the research result?
The research stage has been successfully closed; development is now entering the preclinical trial phase.

They are looking for product development partners to develop the transfection kit through a licence agreement.

 

 

 

 

 

KEYWORDS QUANTITATIVE ASSESSMENT (0-5).

 

Please put X as appropriate. 1 2 3 4 5
Adequacy of testing activity undertaken so far         X
Adequacy and availability of technical resources of the development team     X    
Current development stage     X    
Overall technical feasibility         X

 

Bookmark the permalink. Follow any comments here with the RSS feed for this post. Post a comment or leave a trackback: Trackback URL.

Post a Comment

You must be logged in to post a comment.

Request a proposal

Valorisation Plan Authors

Related Documents

There in no related documents

Visit the other applications of the INTERVALUE Platform: R&D Repository | IP Agreements

© 2009-2010 INTERVALUE Project